Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
about
Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birthPrenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birthVaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trialProgesterone to prevent spontaneous preterm birthVaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM studyBridging progestogens in pregnancy and pregnancy preventionEffectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysisA blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix.Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient dataThe role of progesterone in prevention of preterm birth.Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle.Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.Progesterone use after successful treatment of threatened pre-term delivery.The influence of prior obstetrical history on current 17-hydroxyprogesterone caproate use.A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.Progestin treatment for the prevention of preterm birth.Thermosensitive progesterone hydrogel: a safe and effective new formulation for vaginal application.Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birthOutcome of vaginal progesterone as a tocolytic agent: randomized clinical trialUse and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitalsEvaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.Comparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical TrialVaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancyInadvertent P-hacking among trials and systematic reviews of the effect of progestogens in pregnancy? A systematic review and meta-analysis.Medroxyprogesterone acetate modulates remodeling, immune cell census, and nerve fibers in the cervix of a mouse model for inflammation-induced preterm birthVaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysisCare for women with prior preterm birth.Vaginal progesterone on the prevention of preterm birth and neonatal complications in high risk women: A randomized placebo-controlled double-blind study.Preterm Birth Prevention: Effects of Vaginal Progesterone Administration on Blood Flow Impedance in Uterine-Fetal Circulation by Doppler Sonography.Progesterone for the prevention of preterm birth: indications, when to initiate, efficacy and safetyProgestational agents for the prevention of preterm birth.The negative regulators of the host immune response: an unexplored pathway in preterm birth.Progesterone to prevent preterm birth in twin gestations: what is the next step forward?Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialThe interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth riskActions of progestins for the inhibition of cervical ripening and uterine contractions to prevent preterm birth.The role of progesterone in maternal and fetal medicine.Progestogens for preterm birth prevention: a systematic review and meta-analysis by drug route.The rebirth of progesterone in the prevention of preterm labor.
P2860
Q24200953-C5D97A3C-910A-49D1-9FFC-B3B812D50EA8Q24244821-FD8AB77D-222C-47F0-A187-939C7F27BFDFQ24622553-8CF9CB9E-FE4F-4674-BF29-1C8020A6D911Q26827262-553C2121-4B7D-43FB-97EA-A46AD1EC29B5Q28069874-378286E0-CB50-419A-AD60-29F405D76414Q28082015-746A791D-067E-47E0-B835-3E1E12BDC011Q30844080-DF655B23-E244-4D5B-BCDF-0BF22D5D1A8EQ33886845-07BC2E0A-9B1E-43C6-8DBC-84D692AF9423Q34119248-CADF2250-0BE2-429A-90AB-6794F0805478Q34143212-9F214098-90FC-4F7E-8206-B4574557A40BQ34271918-7266C778-C175-4446-BF1E-7BC8047D0B22Q34620970-F95BD263-DA40-4CD6-B3AA-F3DFACE37CB9Q34629600-D820350E-A8CD-455D-B6E7-B73BF145B827Q35017662-D3636CD6-2B6E-4DBB-8195-9E1FEC68A38EQ35101424-1861B8B8-CFDE-4CFB-8C32-CBC922270B22Q35156867-4CE3D879-9F46-44F3-B089-32C9DA1DD3B8Q35223822-068D4131-132A-4513-A897-CB1297D6FD5FQ35674138-8682BEB5-7C86-4B99-B330-F65AB4E40657Q35703067-93570EF5-7116-4AAD-BED5-7B42EA77316CQ36004789-E42B2450-8C06-4528-8182-CF329CC7B425Q36016724-DBFDB074-869F-47D1-982E-F77BB3CD079AQ36095536-C3D20D82-54BA-4CC8-9C02-7A5CC3075B43Q36217310-8C5C9200-74B5-4BD0-801D-DF4014419E68Q36311625-D8BE3072-68AB-4E57-AC34-00A11B4D5E27Q36314361-EA38A0BE-201E-4911-91A4-8FFCFD5E928BQ36328567-9E62094D-7D08-48A8-BBE3-29C73A3D7500Q36487287-9A9F3886-DA72-4DAA-A8C5-4DC9046A92ABQ36829111-EE00705F-CB4C-45DC-989C-EA3EEA8464B9Q37010395-964C6341-83D4-4535-BFE0-7579272ACBA9Q37137051-C08B09ED-EF71-4CFA-85D4-5BFF52CDF5ADQ37230248-0235E9F0-87F7-4AE0-8122-55F2C97FDBD1Q37322420-6A7AE5E3-315A-4821-865F-268FA0B61F88Q37341353-4187516C-AA7E-4247-BE33-9998F0F36983Q37487072-E41D3882-6FCD-4F41-B03E-F8D03CA4714BQ37498149-78C2A086-9DC2-4461-9A47-3D75EA6C15AAQ37593578-CDB53948-CDBF-4E12-84E3-BD32202E9BE3Q37704144-B3AD4272-977A-44D0-8427-209D82768B9DQ38051406-49664B57-C553-425C-A9B2-6124A01E457FQ38093437-F30DC643-697B-413F-BBE6-0B27F49D5432Q38093767-FC53A7C7-828B-4269-B7BE-FE2A76A58D13
P2860
Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@ast
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@en
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@nl
type
label
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@ast
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@en
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@nl
prefLabel
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@ast
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@en
Progesterone vaginal gel for t ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P356
P1476
Progesterone vaginal gel for t ...... lind, placebo-controlled trial
@en
P2093
C Chazotte
D Vidyadhari
E A Defranco
G Valenzuela
P2860
P304
P356
10.1002/UOG.5158
P577
2007-10-01T00:00:00Z